{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T19:28:44Z","timestamp":1795202924043,"version":"4.10.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Cancer Institute"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In the years following pregnancy, breast cancer risk is elevated, particularly for hormone receptor negative (HR-) tumors. Exposure to high maternal circulating estrogens, when the breast is vastly remodeling in structure and morphology, has been associated with HR- tumor risk. Estrogen metabolite profiles in nonpregnant women, notably the ratio of 2:16 hydroxylation (OH) pathway metabolites, are associated with postmenopausal breast cancer development; whether estrogen metabolism during pregnancy influences subsequent HR- breast cancer risk is unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We conducted a population-based case\u2013control study in women 19\u201339\u00a0years identified in the Finnish Maternity Cohort Biobank and linked with the Finnish Cancer Registry to identify breast cancer diagnoses within 20\u00a0years of pregnancy. Estrogens and metabolites were measured using highly reliable and sensitive LC\u2013MS\/MS methods in serum collected during the first and second trimesters of pregnancy. Included were invasive, ER-\/PR- breast cancer cases (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009449) and controls (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009449) matched on maternal age at index pregnancy, parity, calendar year of serum collection, gestational week of blood collection, and number of sample freeze\/thaw cycles. Associations between the estrogens and breast cancer risk were estimated using odds ratios (ORs) with 95% confidence intervals (CIs) from conditional logistic regression models.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The median years of follow-up between blood collection and breast cancer diagnosis\/control selection was 9 (range 0\u201319). Ninety-three percent of cases were\u2009&lt;\u200950\u00a0years of age at breast cancer diagnosis. Total estrogens were positively associated with ER-\/PR- breast cancer (OR associated with a doubling of total estrogens 1.16; 95% CI 1.02\u20131.32), as were metabolites in the 16-pathway including estriol [OR 1.11; 95% CI 1.01\u20131.22], 16-epiestriol [OR 1.11; 95% CI 1.01\u20131.21)], 17-epiestriol [OR 1.06; 95% CI 1.01\u20131.13], and total 16-hydroxylation pathway metabolites [OR 1.11; 95% CI 1.00\u20131.24]. There was no clear association with the ratio of 2:16 hydroxylation pathway metabolites. Some associations differed by parity, age at diagnosis, and gestational timing of blood collection, but interactions were not statistically significant. Results were similar when restricted to cases occurring within 15\u00a0years since pregnancy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This prospective study demonstrated positive associations of estrogen metabolites in pregnancy and risk of mostly premenopausal ER-\/PR- breast cancer, but the magnitudes varied by metabolite. No strong or consistent pattern for one metabolic pathway emerged suggesting that total estrogen concentrations during pregnancy are associated with subsequent HR- breast cancer development, regardless of how they are metabolized.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13058-025-02204-5","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T08:26:45Z","timestamp":1768552005000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Estrogen metabolism pathways in pregnancy and subsequent breast cancer risk: a prospective follow-up study"],"prefix":"10.1186","volume":"28","author":[{"given":"R.","family":"Troisi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. T.","family":"Falk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. M.","family":"Surcel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kauppila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Mirtti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gissler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Sampson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. L.","family":"Gierach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"2204_CR1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.7326\/M18-1323","volume":"170","author":"HB Nichols","year":"2019","unstructured":"Nichols HB, Schoemaker MJ, Cai J, Xu J, Wright LB, Brook MN, et al. Breast cancer risk after recent childbirth: a pooled analysis of 15 prospective studies. Ann Intern Med. 2019;170:22\u201330.","journal-title":"Ann Intern Med"},{"key":"2204_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-025-07806-3","author":"CFJ Bakhuis","year":"2025","unstructured":"Bakhuis CFJ, Prekovi\u0107 S, Suelmann BBM, Verloop J, Westenend PJ, Linn SC, et al. Worse prognosis for breast cancer diagnosed in advanced pregnancy and shortly postpartum: an update of the Dutch pregnancy-associated breast cancer cohort. Breast Cancer Res Treat. 2025. https:\/\/doi.org\/10.1007\/s10549-025-07806-3.","journal-title":"Breast Cancer Res Treat."},{"key":"2204_CR3","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/1471-2407-10-226","volume":"10","author":"G Albrektsen","year":"2010","unstructured":"Albrektsen G, Heuch I, Thoresen S\u00d8. Histological type and grade of breast cancer tumors by parity, age at birth, and time since birth: a register-based study in Norway. BMC Cancer. 2010;10:226.","journal-title":"BMC Cancer"},{"key":"2204_CR4","first-page":"361","volume":"11","author":"JD Peck","year":"2002","unstructured":"Peck JD, Hulka BS, Poole C, Savitz DA, Baird D, Richardson BE. Steroid hormone levels during pregnancy and incidence of maternal breast cancer. Cancer Epidemiol Biomarkers Prev. 2002;11:361\u20138.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2204_CR5","doi-asserted-by":"publisher","first-page":"6958","DOI":"10.1158\/0008-5472.CAN-14-2150","volume":"74","author":"RT Fortner","year":"2014","unstructured":"Fortner RT, Schock H, Kaaks R, Lehtinen M, Pukkala E, Lakso H\u00c5, et al. Early pregnancy sex steroids and maternal breast cancer: a nested case-control study. Cancer Res. 2014;74:6958\u201367.","journal-title":"Cancer Res"},{"key":"2204_CR6","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13058-017-0876-8","volume":"19","author":"RT Fortner","year":"2017","unstructured":"Fortner RT, Tolockiene E, Schock H, Oda H, Lakso H\u00c5, Hallmans G, et al. Early pregnancy sex steroids during primiparous pregnancies and maternal breast cancer: a nested case-control study in the Northern Sweden Maternity Cohort. Breast Cancer Res. 2017;19:82.","journal-title":"Breast Cancer Res"},{"key":"2204_CR7","doi-asserted-by":"publisher","first-page":"3739","DOI":"10.1210\/jc.2016-3476","volume":"102","author":"BA Cohn","year":"2017","unstructured":"Cohn BA, Cirillo PM, Hopper BR, Siiteri PK. Third trimester estrogens and maternal breast cancer: prospective evidence. J Clin Endocrinol Metab. 2017;102:3739\u201348.","journal-title":"J Clin Endocrinol Metab"},{"key":"2204_CR8","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1002\/ijc.26070","volume":"130","author":"A Lukanova","year":"2012","unstructured":"Lukanova A, Surcel HM, Lundin E, Kaasila M, Lakso HA, Schock H, et al. Circulating estrogens and progesterone during primiparous pregnancies and risk of maternal breast cancer. Int J Cancer. 2012;130:910\u201320.","journal-title":"Int J Cancer"},{"key":"2204_CR9","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1158\/0008-5472.CAN-16-1717","volume":"77","author":"JN Sampson","year":"2017","unstructured":"Sampson JN, Falk RT, Schairer C, Moore SC, Fuhrman BJ, Dallal CM, et al. Association of estrogen metabolism with breast cancer risk in different cohorts of postmenopausal women. Cancer Res. 2017;77:918\u201325.","journal-title":"Cancer Res"},{"key":"2204_CR10","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1158\/0008-5472.CAN-11-2507","volume":"72","author":"AH Eliassen","year":"2012","unstructured":"Eliassen AH, Spiegelman D, Xu X, Keefer LK, Veenstra TD, Barbieri RL, et al. Urinary estrogens and estrogen metabolites and subsequent risk of breast cancer among premenopausal women. Cancer Res. 2012;72:696\u2013706.","journal-title":"Cancer Res"},{"issue":"12","key":"2204_CR11","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1530\/EC-21-0226","volume":"10","author":"X Li","year":"2021","unstructured":"Li X, Ling Fang L, Li H, Yang X. Urinary estrogen metabolites and breast cancer risk in Chinese population. Endocr Connect. 2021;10(12):1615\u201322.","journal-title":"Endocr Connect"},{"key":"2204_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ejca.2017.02.017","volume":"77","author":"MK Leinonen","year":"2017","unstructured":"Leinonen MK, Miettinen J, Heikkinen S, Pitk\u00e4niemi J, Malila N. Quality measures of the population-based Finnish Cancer Registry indicate sound data quality for solid malignant tumours. Eur J Cancer. 2017;77:31\u20139.","journal-title":"Eur J Cancer"},{"key":"2204_CR13","doi-asserted-by":"publisher","first-page":"7813","DOI":"10.1021\/ac070494j","volume":"79","author":"X Xu","year":"2007","unstructured":"Xu X, Roman JM, Issaq HJ, Keefer LK, Veenstra TD, Ziegler RG. Quantitative measurement of endogenous estrogens and estrogen metabolites in human serum by liquid chromatography-tandem mass spectrometry. Anal Chem. 2007;79:7813\u201321.","journal-title":"Anal Chem"},{"key":"2204_CR14","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1158\/1055-9965.EPI-14-0438","volume":"23","author":"BJ Fuhrman","year":"2014","unstructured":"Fuhrman BJ, Xu X, Falk RT, Dallal CM, Veenstra TD, Keefer LK, et al. Assay reproducibility and interindividual variation for 15 serum estrogens and estrogen metabolites measured by liquid chromatography-tandem mass spectrometry. Cancer Epidemiol Biomarkers Prev. 2014;23:2649\u201357.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2204_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djae172","author":"AN Hurson","year":"2024","unstructured":"Hurson AN, Ahearn TU, Koka H, Jenkins BD, Harris AR, Roberts S, et al. Risk factors for breast cancer subtypes by race and ethnicity: a scoping review. J Natl Cancer Inst. 2024. https:\/\/doi.org\/10.1093\/jnci\/djae172.","journal-title":"J Natl Cancer Inst"},{"key":"2204_CR16","doi-asserted-by":"crossref","unstructured":"Henderson BE, Ponder B, Ross RK. Hormones, genes, and cancer. Oxford University Press; 2003. p. 25.","DOI":"10.1093\/oso\/9780195135763.001.0001"},{"key":"2204_CR17","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1093\/jnci\/djr257","volume":"103","author":"WF Anderson","year":"2011","unstructured":"Anderson WF, Katki HA, Rosenberg PS. Incidence of Breast Cancer in the United States: current and future trends. J Natl Cancer Inst. 2011;103:1397\u2013402.","journal-title":"J Natl Cancer Inst"},{"key":"2204_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-3-030-41596-9_1","volume":"1252","author":"A Alex","year":"2020","unstructured":"Alex A, Bhandary E, McGuire KP. Anatomy and physiology of the breast during pregnancy and lactation. Adv Exp Med Biol. 2020;1252:3\u20137.","journal-title":"Adv Exp Med Biol"},{"key":"2204_CR19","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1038\/s41467-020-16479-z","volume":"11","author":"MJ Feigman","year":"2020","unstructured":"Feigman MJ, Moss MA, Chen C, Cyrill SL, Ciccone MF, Trousdell MC, et al. Pregnancy reprograms the epigenome of mammary epithelial cells and blocks the development of premalignant lesions. Nat Commun. 2020;11:2649.","journal-title":"Nat Commun"},{"key":"2204_CR20","doi-asserted-by":"publisher","first-page":"e20224","DOI":"10.1016\/j.heliyon.2023.e20224","volume":"9","author":"K Al-Shami","year":"2023","unstructured":"Al-Shami K, Awadi S, Khamees A, Alsheikh AM, Al-Sharif S, Ala\u2019 Bereshy R, et al. Estrogens and the risk of breast cancer: a narrative review of literature. Heliyon. 2023;9:e20224.","journal-title":"Heliyon"},{"key":"2204_CR21","doi-asserted-by":"publisher","first-page":"dju237","DOI":"10.1093\/jnci\/dju237","volume":"106","author":"JR Palmer","year":"2014","unstructured":"Palmer JR, Viscidi E, Troester MA, Hong C-C, Schedin P, Bethea TN, et al. Parity, lactation, and breast cancer subtypes in African American women: results from the AMBER consortium. JNCI. 2014;106:dju237.","journal-title":"JNCI"},{"key":"2204_CR22","first-page":"1079","volume":"2010","author":"S Laanter\u00e4","year":"2010","unstructured":"Laanter\u00e4 S, P\u00f6lkki T, Ekstr\u00f6m A, Pietil\u00e4 A-M. Breastfeeding attitudes of Finnish parents during pregnancy. BMC Pregnancy Childbirth. 2010;2010:1079.","journal-title":"BMC Pregnancy Childbirth"},{"key":"2204_CR23","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1080\/02841860701592400","volume":"47","author":"K Holl","year":"2008","unstructured":"Holl K, Lundin E, Kaasila M, Grankvist K, Afanasyeva Y, Hallmans G, et al. Effect of long-term storage on hormone measurements in samples from pregnant women: the experience of the Finnish Maternity Cohort. Acta Oncol. 2008;47:406\u201312.","journal-title":"Acta Oncol"},{"key":"2204_CR24","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.clinbiochem.2012.01.012","volume":"45","author":"C Oddoze","year":"2012","unstructured":"Oddoze C, Lombard E, Portugal H. Stability study of 81 analytes in human whole blood, in serum and in plasma. Clin Biochem. 2012;45:464\u20139.","journal-title":"Clin Biochem"},{"key":"2204_CR25","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/S0015-0282(01)01986-0","volume":"76","author":"R Reyna","year":"2001","unstructured":"Reyna R, Traynor KD, Hines G, Boots LR, Azziz R. Repeated freezing and thawing does not generally alter assay results for several commonly studied reproductive hormones. Fertil Steril. 2001;76:823\u20135.","journal-title":"Fertil Steril"},{"key":"2204_CR26","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1210\/jc.2015-1040","volume":"100","author":"LM Demers","year":"2015","unstructured":"Demers LM, Hankinson SE, Haymond S, Key T, Rosner W, Santen RJ, et al. Measuring estrogen exposure and metabolism: workshop recommendations on clinical issues. J Clin Endocrinol Metab. 2015;100:2165\u201370.","journal-title":"J Clin Endocrinol Metab"},{"key":"2204_CR27","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jsbmb.2015.02.003","volume":"149","author":"F Labrie","year":"2015","unstructured":"Labrie F, Ke Y, Gonthier R, B\u00e9langer A. Why both LC-MS\/MS and FDA-compliant validation are essential for accurate estrogen assays? J Steroid Biochem Mol Biol. 2015;149:89\u201391.","journal-title":"J Steroid Biochem Mol Biol"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-025-02204-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-025-02204-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-025-02204-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T01:04:35Z","timestamp":1770771875000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13058-025-02204-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2204"],"URL":"https:\/\/doi.org\/10.1186\/s13058-025-02204-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8022341\/v1","asserted-by":"object"}]},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"3 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The linkage of the FMC data with the Finnish health registers was approved by the data protection authorities at the Finnish Institute for Health and Welfare (Dnro THL\/729\/5.05.00\/2017). The study design and ethics were approved by the Scientific Committee of Biobank Borealis of Northern Finland (BB_2018_2015), University of Oulu, Finland. Data handling was performed according to the Finnish data protection legislation and the rules of the Finnish Institute of Health and Welfare. Because the data concerning the offspring (probands and controls) were completely register-based, personal informed consent was not required. The authors had no access to personal identification data, only pseudonymized data were analyzed. An exemption from Institutional Review Board review was obtained from the Office of Human Subjects Research at the NIH.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43"}}